Mabylon
Schlieren
About Mabylon
Mabylon is a biotechnology company that leverages a technology platform to discover and engineer antibody therapeutics. It focuses on therapies for allergies, inflammation, and neurology. The company's goal is to rapidly create antibody libraries from which therapeutically relevant products are selected.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $38.8M
- Last round: Undisclosed (Aug 2025)
- Website: mabylon.com
- Phone: 41 44 731 94 09
Industries & Categories
Biotechnology, Health Care, Neuroscience, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/mabylon-14525 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.